Intralink-Spine Inc (ILS) reported on Tuesday the receipt of the ISO 13485:2016 certification for its Quality Management System (QMS).
Following a review by MedCert GmbH, the ISO certification reflects ILS' commitment to the highest level of medical device quality controls and meeting customer and international regulatory expectations as it prepares for commercialization.
The certification process included an on-site audit of ILS's newly constructed GMP manufacturing facility in Lexington, KY. Its manufacturing facility for Réjuve production conveyed its commitment to product quality. It has the necessary infrastructure and controls to produce Réjuve in compliance with all quality requirements, states Bruce Choi, VP Quality & Operations.
ILS said it was formed to manufacture and exclusively sell the Réjuve medical device to treat Degenerative Disc Disease (DDD), low back pain and related spinal diseases including spondylolisthesis.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project